Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications

肝星状细胞 医学 纤维化 肝硬化 肝纤维化 非酒精性脂肪肝 肝病 肌成纤维细胞 癌症研究 疾病 内科学 慢性肝病 病理 脂肪肝
作者
Scott L. Friedman
出处
期刊:Nature Clinical Practice Gastroenterology & Hepatology [Nature Portfolio]
卷期号:1 (2): 98-105 被引量:496
标识
DOI:10.1038/ncpgasthep0055
摘要

Hepatic fibrosis, or scarring of the liver, is emerging as a treatable complication of advanced liver disease, following significant progress in understanding its underlying mechanisms. Efforts have focused on the hepatic stellate cell, as these cells can undergo 'activation' into proliferative and fibrogenic myofibroblast-like cells during liver injury. Stimuli driving stellate cell activation include hepatocellular necrosis due to oxidant stress, apoptosis, and soluble growth factors. Specific lymphocyte subsets can also stimulate fibrogenesis. A cascade of signaling and transcriptional events in stellate cells underlies the fibrogenic response to liver injury, with each step in the cascade being a potential target for antifibrotic therapy. Disease-specific fibrogenic mechanisms have also been uncovered: in hepatitis C, this may include direct stimulation of stellate cell activation by viral infection; in nonalcoholic steatohepatitis, elevated levels of leptin and increased leptin signaling by stellate cells increase fibrogenesis. Determinants of fibrosis progression include both environmental and genetic factors, with ongoing efforts to define specific polymorphisms correlating with fibrosis progression rates. Human studies now indicate that fibrosis and even cirrhosis could be reversible, especially if the underlying disease is eradicated. A key challenge is to establish noninvasive means of assessing fibrosis stage and progression using either serum tests and/or imaging. In addition, endpoints of antifibrotic clinical trials need to be established so that reliable evidence of benefit can be identified. We are on the cusp of a new era in which antifibrotic therapies could become important in treating chronic fibrosing liver disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
旺旺发布了新的文献求助10
刚刚
慕青的应助被胡萝卜卜采纳,获得10
刚刚
赘婿的应助被Wenlia采纳,获得10
刚刚
刚刚
mostspecial发布了新的文献求助30
刚刚
声声慢发布了新的文献求助10
1秒前
俊逸的问兰完成签到,获得积分10
1秒前
共享精神的应助被milv5采纳,获得10
1秒前
1秒前
myjf发布了新的文献求助10
2秒前
2秒前
.....发布了新的文献求助10
2秒前
飘飘发布了新的文献求助10
2秒前
CipherSage的应助被CY采纳,获得10
3秒前
小刘很怕忙完成签到,获得积分10
3秒前
3秒前
ding的应助被观莲客采纳,获得10
3秒前
英姑的应助被葉子采纳,获得10
3秒前
陈丽陈丽发布了新的文献求助10
4秒前
4秒前
4秒前
万能图书馆的应助被zz采纳,获得10
4秒前
4秒前
5秒前
5秒前
5秒前
5秒前
WangC发布了新的文献求助10
5秒前
6秒前
ww发布了新的文献求助10
6秒前
6秒前
6秒前
春桑早点睡完成签到,获得积分10
6秒前
方曦辉发布了新的文献求助10
7秒前
你别管了发布了新的文献求助10
7秒前
君念生完成签到,获得积分10
7秒前
7秒前
lily完成签到,获得积分10
7秒前
阿俞的应助被三千采纳,获得10
8秒前
充电宝的应助被别梦寒采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162816
求助须知:如何正确求助?哪些是违规求助? 9557103
关于积分的说明 21738393
捐赠科研通 7753330
什么是DOI,文献DOI怎么找? 3427963
关于科研通互助平台的介绍 2552742
邀请新用户注册赠送积分活动 2472556